Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

493 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neuromonitoring in neonatal critical care part I: neonatal encephalopathy and neonates with possible seizures.
El-Dib M, Abend NS, Austin T, Boylan G, Chock V, Cilio MR, Greisen G, Hellström-Westas L, Lemmers P, Pellicer A, Pressler RM, Sansevere A, Tsuchida T, Vanhatalo S, Wusthoff CJ; Newborn Brain Society Guidelines and Publications Committee. El-Dib M, et al. Among authors: austin t. Pediatr Res. 2023 Jul;94(1):64-73. doi: 10.1038/s41390-022-02393-1. Epub 2022 Dec 7. Pediatr Res. 2023. PMID: 36476747 Review.
Clinical use of cerebral oximetry in extremely preterm infants is feasible.
Hyttel-Sørensen S, Austin T, van Bel F, Benders M, Claris O, Dempsey EM, Fumagalli M, Gluud C, Hagmann C, Hellström-Westas L, Lemmers P, Naulaers G, van Oeveren W, Pellicer A, Pichler G, Roll C, Støy LS, Wolf M, Greisen G. Hyttel-Sørensen S, et al. Among authors: austin t. Dan Med J. 2013 Jan;60(1):A4533. Dan Med J. 2013. PMID: 23340184 Free article. Clinical Trial.
A phase II randomized clinical trial on cerebral near-infrared spectroscopy plus a treatment guideline versus treatment as usual for extremely preterm infants during the first three days of life (SafeBoosC): study protocol for a randomized controlled trial.
Hyttel-Sorensen S, Austin T, van Bel F, Benders M, Claris O, Dempsey E, Fumagalli M, Greisen G, Grevstad B, Hagmann C, Hellström-Westas L, Lemmers P, Lindschou J, Naulaers G, van Oeveren W, Pellicer A, Pichler G, Roll C, Skoog M, Winkel P, Wolf M, Gluud C. Hyttel-Sorensen S, et al. Among authors: austin t. Trials. 2013 May 1;14:120. doi: 10.1186/1745-6215-14-120. Trials. 2013. PMID: 23782447 Free PMC article. Clinical Trial.
The SafeBoosC phase II randomised clinical trial: a treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants.
Pellicer A, Greisen G, Benders M, Claris O, Dempsey E, Fumagalli M, Gluud C, Hagmann C, Hellström-Westas L, Hyttel-Sorensen S, Lemmers P, Naulaers G, Pichler G, Roll C, van Bel F, van Oeveren W, Skoog M, Wolf M, Austin T. Pellicer A, et al. Among authors: austin t. Neonatology. 2013;104(3):171-8. doi: 10.1159/000351346. Epub 2013 Aug 1. Neonatology. 2013. PMID: 23921600 Free article. Clinical Trial.
Cerebral near infrared spectroscopy oximetry in extremely preterm infants: phase II randomised clinical trial.
Hyttel-Sorensen S, Pellicer A, Alderliesten T, Austin T, van Bel F, Benders M, Claris O, Dempsey E, Franz AR, Fumagalli M, Gluud C, Grevstad B, Hagmann C, Lemmers P, van Oeveren W, Pichler G, Plomgaard AM, Riera J, Sanchez L, Winkel P, Wolf M, Greisen G. Hyttel-Sorensen S, et al. Among authors: austin t. BMJ. 2015 Jan 5;350:g7635. doi: 10.1136/bmj.g7635. BMJ. 2015. PMID: 25569128 Free PMC article. Clinical Trial.
Is near-infrared spectroscopy clinically useful in the preterm infant?
da Costa CS, Greisen G, Austin T. da Costa CS, et al. Among authors: austin t. Arch Dis Child Fetal Neonatal Ed. 2015 Nov;100(6):F558-61. doi: 10.1136/archdischild-2014-307919. Epub 2015 Jul 27. Arch Dis Child Fetal Neonatal Ed. 2015. PMID: 26215405 Review.
Brain injury in the international multicenter randomized SafeBoosC phase II feasibility trial: cranial ultrasound and magnetic resonance imaging assessments.
Plomgaard AM, Hagmann C, Alderliesten T, Austin T, van Bel F, Claris O, Dempsey E, Franz A, Fumagalli M, Gluud C, Greisen G, Hyttel-Sorensen S, Lemmers P, Pellicer A, Pichler G, Benders M. Plomgaard AM, et al. Among authors: austin t. Pediatr Res. 2016 Mar;79(3):466-72. doi: 10.1038/pr.2015.239. Epub 2015 Nov 16. Pediatr Res. 2016. PMID: 26571218 Free PMC article. Clinical Trial.
The SafeBoosC phase II clinical trial: an analysis of the interventions related with the oximeter readings.
Riera J, Hyttel-Sorensen S, Bravo MC, Cabañas F, López-Ortego P, Sanchez L, Ybarra M, Dempsey E, Greisen G, Austin T, Claris O, Fumagalli M, Gluud C, Lemmers P, Pichler G, Plomgaard AM, van Bel F, Wolf M, Pellicer A. Riera J, et al. Among authors: austin t. Arch Dis Child Fetal Neonatal Ed. 2016 Jul;101(4):F333-8. doi: 10.1136/archdischild-2015-308829. Epub 2015 Dec 8. Arch Dis Child Fetal Neonatal Ed. 2016. PMID: 26645538 Free PMC article. Clinical Trial.
The SafeBoosC II randomized trial: treatment guided by near-infrared spectroscopy reduces cerebral hypoxia without changing early biomarkers of brain injury.
Plomgaard AM, van Oeveren W, Petersen TH, Alderliesten T, Austin T, van Bel F, Benders M, Claris O, Dempsey E, Franz A, Fumagalli M, Gluud C, Hagmann C, Hyttel-Sorensen S, Lemmers P, Pellicer A, Pichler G, Winkel P, Greisen G. Plomgaard AM, et al. Among authors: austin t. Pediatr Res. 2016 Apr;79(4):528-35. doi: 10.1038/pr.2015.266. Epub 2015 Dec 17. Pediatr Res. 2016. PMID: 26679155 Free PMC article. Clinical Trial.
Early biomarkers of brain injury and cerebral hypo- and hyperoxia in the SafeBoosC II trial.
Plomgaard AM, Alderliesten T, Austin T, van Bel F, Benders M, Claris O, Dempsey E, Fumagalli M, Gluud C, Hagmann C, Hyttel-Sorensen S, Lemmers P, van Oeveren W, Pellicer A, Petersen TH, Pichler G, Winkel P, Greisen G. Plomgaard AM, et al. Among authors: austin t. PLoS One. 2017 Mar 22;12(3):e0173440. doi: 10.1371/journal.pone.0173440. eCollection 2017. PLoS One. 2017. PMID: 28328980 Free PMC article. Clinical Trial.
493 results